(Q33504241)

English

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.

scientific article

Statements

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit